灭活流感疫苗不能减少有基础疾病儿童的全因呼吸道疾病
本研究基于2004—2015年荷兰初级保健电子记录,纳入11,797名符合灭活流感疫苗(IIV)接种指征的6月龄至18岁儿童,比较当季接种与未接种者在流感流行期因呼吸道疾病就诊的风险,调整后OR为1.01(95%CI 0.90-1.13),敏感性分析结果一致,提示IIV未减少初级保健中全因呼吸道疾病就诊。
要点
- 在11,797名有基础疾病的儿童中,当季接种IIV与未接种者流感流行期因呼吸道疾病就诊的调整OR为1.01(95%CI 0.90-1.13)。
- 排除疫苗株与流行株不匹配的季节、将流感期限制为哨点监测阳性率至少30%的周、使用倾向评分调整后,结果均相近。
- 作者结论为:有基础疾病儿童接种IIV不能减少流感季节初级保健中全因呼吸道疾病就诊。
核心结论
- 有基础疾病的儿童接种灭活流感疫苗不能减少流感季节在初级保健中因全因呼吸道疾病就诊。
研究设计与样本
- 研究类型为观察性研究,使用2004—2015年荷兰初级保健电子记录。
- 纳入11,797名6月龄至18岁符合荷兰指南IIV接种指征的儿童,随访38,701儿童年,其中29%至少接种过一次。
- 采用广义估计方程分析当季接种状态与流感流行期至少一次呼吸道疾病就诊的关联,以当季接种为参照组。
主要发现
- 当季接种与未接种儿童在流感流行期因呼吸道疾病就诊的调整OR为1.01(95%CI 0.90-1.13)。
- 排除疫苗株与优势流行株不匹配的季节、将流感期限制为哨点监测阳性率至少30%的周、使用倾向评分调整后,结果相近。
关键数值与推荐
- 荷兰指南IIV接种指征包括(慢性)呼吸系统疾病、心血管疾病和糖尿病。
- 主要结局为流感流行期至少一次因呼吸道疾病(包括流感、急性呼吸道感染和哮喘急性发作)的初级保健就诊。
- 敏感性分析中流感期限制为哨点监测中流感病毒阳性标本至少30%的周(而非5%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The effectiveness of inactivated influenza vaccine (IIV) immunization in preventing all cause respiratory illness (RI) in children with pre-existing medical conditions has not been fully established and varies from season to season. This study aims to quantify the overall impact of IIV immunization on primary care attended RI episodes in children with pre-existing medical conditions, using robust observational data spanning twelve influenza seasons. METHODS: Electronic records of IIV eligible children aged 6 months to 18 years were extracted from primary care databases over the years 2004-2015. IIV eligibility criteria according to Dutch guidelines included (chronic) respiratory and cardiovascular disease and diabetes mellitus. For each year, information on IIV immunization status, primary care attended RI episodes (including influenza, acute respiratory tract infections and asthma exacerbations) and potential confounders were collected. Generalized estimating equations were used to model the association between IIV status and occurrence of at least one RI episode during the influenza epidemic period with "current year immunized" as reference group. Robustness of findings were assessed by performing various sensitivity analyzes in which (i) seasons with a mismatch between the dominant circulating influenza virus and vaccine strain were excluded, (ii) influenza periods were further restricted to weeks with at least 30% influenza virus positive specimens in sentinel surveillance (instead of 5%), (iii) propensity scores were used to adjust for confounding. RESULTS: In total, 11,797 children (follow-up duration: 38,701 child-years) were eligible for IIV for ≥ one season with 29% immunized at least once. The adjusted odds for primary care attended RI episodes during the influenza epidemic period did not differ between current season immunized versus not immunized children (adjusted OR:1.01; 95%CI:0.90-1.13). The various sensitivity analysis showed comparable results. CONCLUSIONS: IIV immunization in children with pre-existing medical conditions does not reduce all cause RI episodes encountered in primary care during the influenza season.
引用
- de Hoog MLA, Venekamp RP, Meijer A, et al. Inactivated influenza vaccine does not reduce all cause respiratory illness in children with pre-existing medical conditions. Vaccine. 2019. PMID: 31859200. doi:10.1016/j.vaccine.2019.11.086
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。